>> Watch the Weight Loss Destroyed Video about the myths of weight loss and what you need to know. This is a Discount Link
Rosen Law Firm reminds purchasers of Albany Molecular Research, Inc. common stock (Nasdaq:AMRI) between August 5, 2014 and November 5, 2014 of the important January 12, 2015 lead plaintiff deadline in the class action filed by the firm.
To join the Albany Molecular class action, go to the website at http://www.rosenlegal.com/cases-428.html or call Phillip Kim, Esq. or Laurence Rosen, Esq. toll-free at 866-767-3653 or email email@example.com or firstname.lastname@example.org for information on the class action. The suit is pending in U.S. District Court for the Eastern District of New York.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, Albany Molecular issued materially false and misleading statements about its business and financial prospects. On August 5, 2014, Albany Molecular announced its second quarter 2014 results and increased its 2014 adjusted EPS guidance to $0.87 – $0.92 to reflect the addition of OsoBio and strengthening of its contract business. On November 5, 2014, the Albany Molecular reported a loss of $8.6 million in its third quarter and lowered its 2014 adjusted EPS guidance to $0.67 and $0.73. It disclosed that a business interruption event at its OsoBio facility in late July, prior to its increased EPS estimates in August, contributed to a weak third quarter and the facility will not be back online until mid-November. On this news, shares of Albany Molecular Research fell sharply during intraday trading on November 5, 2014, damaging investors.
If you wish to join the litigation and recover your losses go to http://www.rosenlegal.com/cases-428.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
– See more at: http://globenewswire.com/news-release/2014/12/28/693994/10113499/en/EQUITY-ALERT-Rosen-Law-Firm-Reminds-Albany-Molecular-Research-Inc-Investors-of-Important-Deadline-in-Class-Action-Filed-by-the-Firm-AMRI.html#sthash.FKr9c6Cf.dpuf